EU Regulators Asked To Define 'Drug Shortages' Before Finalizing Notification Framework
Executive Summary
The EU pharmaceutical industry has highlighted key aspects that it wants regulators to address when it comes to defining the term "drug shortages."
You may also be interested in...
What Is A Drug Shortage? First EU Definition Due This Month
Efforts to harmonize the notification and communication requirements for drug shortages in the EU will take a step forward this month when regulators adopt a common definition of a shortage together with a number of guidance documents. The situation with regard to drug shortages has been called a public health emergency.
Simplified Clinical Trial Transparency Rules To Go Live In The EU In June
A new version of the EU Clinical Trials Information System’s public portal will integrate the functionalities of the streamlined transparency rules.
WHO Examines Ethical Criteria For Human Challenge Trials Ahead Of Next Health Emergency
The World Health Organization is looking to finalize its guidance on the ethical criteria that should be applied to studies that involve deliberately infecting healthy individuals to speed up research.